INVESTOR RELATIONS
Corporate Governance
Operating income
Operation revenue
25.435 Billion
Year-on-year increase
3.71 %
Net profit margin
1.33 Billion
R&D investment
Research and development expenditure
1.47 Billion
Year-on-year increase
0.59 %
2023 Research and development expenditure
1.462 Billion
2022 Research and development expenditure
0.967 Billion
2021 Research and development expenditure
0.81 Billion
2020 Research and development expenditure
0.591 Billion
*Unit: CNY Billion
Periodic Temporary
Investor Interaction

If you would like to know about investor relations, please contact us:

ADD: No.666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan, Hubei, China
Email: renfu.pr@renfu.com.cn